Perdigoto David N, Figueiredo Pedro N, Tomé Luís F
Department of Gastroenterology, Coimbra University Hospital Centre.
Faculty of Medicine, Medical School, University of Coimbra, Coimbra, Portugal.
Eur J Gastroenterol Hepatol. 2018 Jun;30(6):645-651. doi: 10.1097/MEG.0000000000001081.
Bacterial infections are frequent in cirrhosis and may induce other deleterious complications. Ultrasensitive C-reactive protein (US-CRP), like other acute-phase proteins, is often considered useful in predicting bacterial infection in decompensated cirrhosis. However, US-CRP's reliability remains inconclusive, as inflammation in cirrhosis causes US-CRP synthesis independently of infection. The aim of this study was to clarify US-CRP's role as an infection predictor in decompensated cirrhosis.
This was a prospective single-center study with systematic inclusion of cirrhotic patients admitted because of decompensation.
A total of 118 patients were enrolled, of whom 47 (39.8%) had an overt infection, defined by clinical and laboratory/imaging criteria. Within those, 17 had infection confirmed by culture bacterial identification. Escherichia coli was the most frequent isolated bacteria. Seventeen patients had spontaneous bacterial peritonitis, but only four (23.5%) had positive ascitic fluid cultures. US-CRP levels were significantly higher in cases of overt infection and positive culture groups than the no infection group (median: 4.14 and 6.40 vs. 1.11 mg/dl, P<0.0001 for both). When considering both overt infection and positive culture groups, the US-CRP values of area under the curve as an infection predictor were, respectively, 0.824 and 0.870, P<0.0001 for both, with associated cutoff values of 2.40 and 3.92 mg/dl, and sensitivity and specificity of 78.7/74.6 and 82.4/79.2%, respectively.
The ideal US-CRP infection confirmatory cutoff is probably situated between 2.40 and 3.92 mg/dl. However, as infection is somewhat concealed and hazardous in cirrhotic patients, if not considered with lower US-CRP levels according to specific clinic scenarios, it should be carefully considered, at least, if US-CRP is greater than 2.40 mg/dl (0.5 mg/dl normal upper cutoff).
细菌感染在肝硬化患者中很常见,并且可能引发其他有害并发症。超敏C反应蛋白(US-CRP)与其他急性期蛋白一样,常被认为有助于预测失代偿期肝硬化患者的细菌感染。然而,US-CRP的可靠性仍无定论,因为肝硬化中的炎症会独立于感染导致US-CRP合成。本研究的目的是阐明US-CRP在失代偿期肝硬化中作为感染预测指标的作用。
这是一项前瞻性单中心研究,系统性纳入因失代偿而入院的肝硬化患者。
共纳入118例患者,其中47例(39.8%)存在显性感染,根据临床及实验室/影像学标准定义。其中,17例经培养细菌鉴定确诊感染。大肠杆菌是最常见的分离细菌。17例患者发生自发性细菌性腹膜炎,但只有4例(23.5%)腹水培养呈阳性。显性感染组和培养阳性组的US-CRP水平显著高于无感染组(中位数:4.14和6.40 vs. 1.11mg/dl,两组P均<0.0001)。当同时考虑显性感染组和培养阳性组时,US-CRP作为感染预测指标的曲线下面积值分别为0.824和0.870,两组P均<0.0001,对应的临界值分别为2.40和3.92mg/dl,敏感性和特异性分别为78.7/74.6和82.4/79.2%。
理想的US-CRP感染确诊临界值可能在2.40至3.92mg/dl之间。然而,由于感染在肝硬化患者中有所隐匿且具有危险性,如果不根据具体临床情况结合较低的US-CRP水平进行考虑,那么至少当US-CRP大于2.40mg/dl(正常上限为0.5mg/dl)时,应予以谨慎考虑。